Home
Home

Lpath

Lpath: The Leader In Lipidomics

Lpath: The Leader In Lipidomics
Seeking Alpha

Age-Related Macular Degeneration: A Promising Investment Opportunity

Age-Related Macular Degeneration: A Promising Investment Opportunity
Seeking Alpha

Lpath Announces Pricing of Public Offering of Common Stock

Lpath Announces Pricing of Public Offering of Common Stock
Yahoo

Lpath's Q3 Filing Shines The Way For A Catalyst Filled 2013

Lpath's Q3 Filing Shines The Way For A Catalyst Filled 2013
Seeking Alpha

Lpath Announces Filing of Shelf Registration Statement

Lpath Announces Filing of Shelf Registration Statement
Yahoo/MarketWire

New Developments In Lipids To Watch Closely

New Developments In Lipids To Watch Closely
Seeking Alpha

Lpath Restarts NEXUS Trial; Breathes New Life Into Shares

Lpath Restarts NEXUS Trial; Breathes New Life Into Shares
Seeking Alpha

Lpath Begins iSONEP Dosing in Nexus Phase 2 Study

Lpath Begins iSONEP Dosing in Nexus Phase 2 Study
Yahoo

Bio Pharma Movers List: Wednesday June 20

Bio Pharma Movers List: Wednesday June 20
Seeking Alpha

Equity Briefing: Speculators buying Lpath, Inc. in anticipation of key catalysts

Equity Briefing: Speculators buying Lpath, Inc. in anticipation of key catalysts
Yahoo